Blocking CCN2 Reduces Established Bone Loss Induced by Prolonged Intense Loading by Increasing Osteoblast Activity in Rats.

Lambi, Alex G; Harris, Michele Y; Amin, Mamta; Joiner, Patrice G; Hilliard, Brendan A; Assari, Soroush; Popoff, Steven N; Barbe, Mary F

Lambi, Alex G; Harris, Michele Y; Amin, Mamta; Joiner, Patrice G; Hilliard, Brendan A; Assari, Soroush; Popoff, Steven N; Barbe, Mary F.

Afiliación

Lambi AG; Department of Orthopedics and Rehabilitation University of New Mexico Albuquerque NM USA.
Harris MY; Center for Translational Medicine, Lewis Katz School of Medicine Temple University Philadelphia PA USA.
Amin M; Center for Translational Medicine, Lewis Katz School of Medicine Temple University Philadelphia PA USA.
Joiner PG; Center for Translational Medicine, Lewis Katz School of Medicine Temple University Philadelphia PA USA.
Hilliard BA; Center for Translational Medicine, Lewis Katz School of Medicine Temple University Philadelphia PA USA.
Assari S; Exponent, Inc. Philadelphia PA USA.
Popoff SN; Department of Biomedical Education and Data Science, Lewis Katz School of Medicine Temple University Philadelphia PA USA.
Barbe MF; Center for Translational Medicine, Lewis Katz School of Medicine Temple University Philadelphia PA USA.

JBMR Plus ; 7(9): e10783, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37701153

Palabras clave

CCN2; CTGF; MUSCULOSKELETAL DISORDERS; OSTEOPENIA; OVERUSE; PAMREVLUMAB

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JBMR Plus Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google